This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
CTS will implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The ...
Reminder: On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the ch...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
The CTS 2020 Annual Laboratory Survey is on its way to your email box. We would appreciate you takin...
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...
We sincerely hope to see you at this year’s AABB Annual Meeting in San Antonio, TX on October ...